Epigallocatechin

Identification

Generic Name
Epigallocatechin
DrugBank Accession Number
DB03823
Background

Not Available

Type
Small Molecule
Groups
Experimental, Investigational
Structure
Weight
Average: 306.2675
Monoisotopic: 306.073952802
Chemical Formula
C15H14O7
Synonyms
  • (-)-epi-gallocatechin
  • (-)-epigallocatechin
  • (-)-epigallocatechol
  • (−)-epigallocatechin
  • 3,3',4',5,5',7-flavanhexol
  • Antiscurvy factor C2
  • EGC
  • Epi-gallocatechin
  • Galloepicatechin
  • L-epigallocatechin
External IDs
  • NSC-674039

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as epigallocatechins. These are compounds containing epigallocatechin or a derivative. Epigallocatechin is a flavan-3-ol containing a benzopyran-3,5,7-triol linked to a 3,4,5-hydroxyphenyl moiety.
Kingdom
Organic compounds
Super Class
Phenylpropanoids and polyketides
Class
Flavonoids
Sub Class
Flavans
Direct Parent
Epigallocatechins
Alternative Parents
7-hydroxyflavonoids / 5-hydroxyflavonoids / 4'-hydroxyflavonoids / 3-hydroxyflavonoids / 3'-hydroxyflavonoids / 1-benzopyrans / Pyrogallols and derivatives / Alkyl aryl ethers / 1-hydroxy-4-unsubstituted benzenoids / 1-hydroxy-2-unsubstituted benzenoids
show 5 more
Substituents
1-benzopyran / 1-hydroxy-2-unsubstituted benzenoid / 1-hydroxy-4-unsubstituted benzenoid / 3'-hydroxyflavonoid / 3-hydroxyflavonoid / 4'-hydroxyflavonoid / 5-hydroxyflavonoid / 7-hydroxyflavonoid / Alcohol / Alkyl aryl ether
show 18 more
Molecular Framework
Aromatic heteropolycyclic compounds
External Descriptors
catechin, flavan-3,3',4',5,5',7-hexol (CHEBI:42255) / Flavans, Flavanols and Leucoanthocyanidins, Flavan 3-ols (C12136) / Flavans, Flavanols and Leucoanthocyanidins (LMPK12020004)
Affected organisms
Not Available

Chemical Identifiers

UNII
7Z197MG6QL
CAS number
970-74-1
InChI Key
XMOCLSLCDHWDHP-IUODEOHRSA-N
InChI
InChI=1S/C15H14O7/c16-7-3-9(17)8-5-12(20)15(22-13(8)4-7)6-1-10(18)14(21)11(19)2-6/h1-4,12,15-21H,5H2/t12-,15-/m1/s1
IUPAC Name
(2R,3R)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol
SMILES
O[C@@H]1CC2=C(O[C@@H]1C1=CC(O)=C(O)C(O)=C1)C=C(O)C=C2O

References

Synthesis Reference

David Burdick, Heinz Egger, Andrew Gum, Ingo Koschinski, Elena Muelchi, Isabelle Prevot-Halter, "Process for the production of (-)-epigallocatechin gallate." U.S. Patent US20060069046, issued March 30, 2006.

US20060069046
General References
Not Available
Human Metabolome Database
HMDB0038361
KEGG Compound
C12136
PubChem Compound
72277
PubChem Substance
46506265
ChemSpider
65231
BindingDB
50187665
ChEBI
42255
ChEMBL
CHEMBL47386
ZINC
ZINC000003870336
PDBe Ligand
EGT
Wikipedia
Gallocatechol
PDB Entries
1jnq / 7eka

Clinical Trials

Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package
PhaseStatusPurposeConditionsCountStart DateWhy Stopped100+ additional columns
2CompletedTreatmentCardiac Involvement / Primary Amyloidosis1somestatusstop reasonjust information to hide
2CompletedTreatmentProstate Cancer1somestatusstop reasonjust information to hide

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.871 mg/mLALOGPS
logP0.71ALOGPS
logP1.49Chemaxon
logS-2.6ALOGPS
pKa (Strongest Acidic)8.73Chemaxon
pKa (Strongest Basic)-3.3Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count7Chemaxon
Hydrogen Donor Count6Chemaxon
Polar Surface Area130.61 Å2Chemaxon
Rotatable Bond Count1Chemaxon
Refractivity75.98 m3·mol-1Chemaxon
Polarizability29.14 Å3Chemaxon
Number of Rings3Chemaxon
Bioavailability1Chemaxon
Rule of FiveNoChemaxon
Ghose FilterYesChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.9654
Blood Brain Barrier-0.5331
Caco-2 permeable-0.8956
P-glycoprotein substrateSubstrate0.5972
P-glycoprotein inhibitor INon-inhibitor0.8953
P-glycoprotein inhibitor IINon-inhibitor0.9734
Renal organic cation transporterNon-inhibitor0.9458
CYP450 2C9 substrateNon-substrate0.8227
CYP450 2D6 substrateNon-substrate0.8771
CYP450 3A4 substrateNon-substrate0.6345
CYP450 1A2 substrateNon-inhibitor0.9046
CYP450 2C9 inhibitorNon-inhibitor0.9071
CYP450 2D6 inhibitorNon-inhibitor0.9231
CYP450 2C19 inhibitorNon-inhibitor0.9041
CYP450 3A4 inhibitorNon-inhibitor0.8309
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.817
Ames testNon AMES toxic0.7658
CarcinogenicityNon-carcinogens0.9539
BiodegradationNot ready biodegradable0.7895
Rat acute toxicity1.8700 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.9666
hERG inhibition (predictor II)Non-inhibitor0.7487
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-000i-0940000000-a9630fe8d1a042f59c2a
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-0a4i-0978700000-567c7251027c80e91a01
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-0a4i-0967700000-febb7658ba2d5bd6d9b6
MS/MS Spectrum - ESI-TOF 10V, NegativeLC-MS/MSsplash10-0a4i-0029000000-82c2dfbbc69b748bc6f3
MS/MS Spectrum - ESI-TOF 30V, NegativeLC-MS/MSsplash10-0a4i-0029000000-82c2dfbbc69b748bc6f3
MS/MS Spectrum - ESI-TOF , NegativeLC-MS/MSsplash10-0pb9-0019003000-c4d2b02a82d1cf14714e
MS/MS Spectrum - ESI-TOF 20V, NegativeLC-MS/MSsplash10-0pb9-0019003000-c4d2b02a82d1cf14714e
MS/MS Spectrum - ESI-TOF 10V, NegativeLC-MS/MSsplash10-0a4i-0029000000-82c2dfbbc69b748bc6f3
MS/MS Spectrum - ESI-TOF 30V, NegativeLC-MS/MSsplash10-002r-0910000000-8dfe0ba4e2ec1225213f
MS/MS Spectrum - ESI-TOF , NegativeLC-MS/MSsplash10-0pb9-0019003000-c4d2b02a82d1cf14714e
MS/MS Spectrum - ESI-TOF 20V, NegativeLC-MS/MSsplash10-00p0-0951000000-95142c4b42b35c4bdac9
MS/MS Spectrum - DI-ESI-qTof , PositiveLC-MS/MSsplash10-000i-0900000000-4e9ebbe814af2f8c284d
MS/MS Spectrum - DI-ESI-qTof , NegativeLC-MS/MSsplash10-05r0-0913000000-be7d3c4d9b40f51414e7
LC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-0a4i-0529000000-0036b0386a7ade78fcac
MS/MS Spectrum - Linear Ion Trap , negativeLC-MS/MSsplash10-00vi-0690000000-702c5a1e065692895b3a
MS/MS Spectrum - Linear Ion Trap , negativeLC-MS/MSsplash10-00vi-0690000000-7844ed1a917693a67b37
LC-MS/MS Spectrum - LC-ESI-TOF , negativeLC-MS/MSsplash10-0a4i-0029000000-82c2dfbbc69b748bc6f3
LC-MS/MS Spectrum - LC-ESI-TOF , negativeLC-MS/MSsplash10-002r-0910000000-8dfe0ba4e2ec1225213f
LC-MS/MS Spectrum - LC-ESI-TOF , negativeLC-MS/MSsplash10-00p0-0951000000-95142c4b42b35c4bdac9
LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-000i-0900000000-c79003b472daf421e492
MS/MS Spectrum - Linear Ion Trap , positiveLC-MS/MSsplash10-000i-0910000000-f92cf1606a46a5b16f4f
MS/MS Spectrum - Linear Ion Trap , positiveLC-MS/MSsplash10-000i-0910000000-2026f33ac95d368b5268
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-0a4r-0289000000-e9a634739c604135b8ca
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-0a4i-0119000000-37870158cc130850047f
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-0a4r-0958000000-dbc47bd114393b103061
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-000i-0971000000-668ebcf4a9095ba26714
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-052r-0940000000-0156be28c97c1a126922
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-01ri-0960000000-e0b6686cd1fd5c464898
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-186.2420872
predicted
DarkChem Lite v0.1.0
[M-H]-185.3655872
predicted
DarkChem Lite v0.1.0
[M-H]-170.75932
predicted
DeepCCS 1.0 (2019)
[M+H]+186.7795872
predicted
DarkChem Lite v0.1.0
[M+H]+187.2535872
predicted
DarkChem Lite v0.1.0
[M+H]+173.11732
predicted
DeepCCS 1.0 (2019)
[M+Na]+185.9095872
predicted
DarkChem Lite v0.1.0
[M+Na]+186.1075872
predicted
DarkChem Lite v0.1.0
[M+Na]+179.4814
predicted
DeepCCS 1.0 (2019)

Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52